North America PET Scanners Market

North America PET Scanners Market Size (2024 to 2029)

The size of the North America PET Scanners Market was worth USD 382.81 million in 2024 and estimated to be growing at a CAGR of 3.12%, to reach USD 446.38 million by 2029. 

The North American PET Scanners Market is majorly promoted by the increased prevalence of chronic illnesses such as cancer.

According to the World Health Organization (WHO), cancer may kill 9.6 million people in 2023, making it the world's second-leading cause of death. Furthermore, the market's rise is aided by the growing acceptability of pets worldwide. In addition, the North American PET Scanners Market is being driven by an increase in cardiac problems due to the world's aging population. Moreover, rising awareness of the benefits of positron emission tomography scanning boosts the market throughout the projected period.

The market is further estimated to be driven by the growth in the frequency of chronic illnesses worldwide, a growing need for improved diagnostic technologies, and expanded Medicare coverage for PET-CT scans. PET methods have been used in cancer diagnosis and monitoring. Still, the upcoming commercial release of numerous new radiotracers that help identify common neurodegenerative disorders like Alzheimer's disease has prompted further PET adoption in neurology. In addition, PET is being more widely used in cardiology for myocardial perfusion imaging, and hence rosining instances of cardiovascular disease will lead to market expansion.

Medicare covers PET scanning is an enormous potential for the PET Scanners Market.

In the following years, the industry is expected to be fuelled by increasing government and private money to provide the best care for patients.The expensive expense of a Positron Emission Tomography (PET) scan is stifling the market's expansion. In addition, the PET Scanners Market is being held back by the short half-life of radioisotopes. Furthermore, the sector is being hammered by strict regulatory constraints governing the use of PET scanners. Moreover, a scarcity of radiopharmaceuticals is stifling the market's expansion.

Countries with limited access to the technology necessary for PTE scanning provide a substantial industry hurdle. PET scanning is a pricey operation; making it accessible for all people is another obstacle that the industry must solve. Buyers who appreciate the continuous uncertainties in the economy and healthcare have grown keenly aware of system qualities linked to configuration scalability, clinical adaptability, and prospective profitability have made purchase and investment value key objectives.

This research report on the North America PET Scanners market has been segmented and sub-segmented into the following categories.

North America PET Scanners Market Analysis By Application

• Oncology 
• Neurology               
• Cardiology              
• Other Applications

North America PET Scanners Market Analysis By Product Type

• Partial Ring PET Scanners 
• Full Ring PET Scanners

North America PET Scanners Market Analysis By Detector Type

• Gadolinium Oxyorthosilicate           
• Lutetium Fine Silicate         
• Bismuth Germanium Oxide             
• Lutetium Oxyorthosilicate               
• Lutetium Yttrium Orthosilicate       

North America PET Scanners Market Analysis By End Users

• Diagnostic Centres               
• Hospitals  
• PET Centres            
• Research Institutes      

North America PET Scanners Market Analysis By Country

• The United States
• Canada
• Rest of North America

Geographically, North America had the largest market for PET Scanners globally by share in 2023.

In the North American region, the United States has the largest share and is expected to grow at the fastest rate. Factors such as the increasing aging population and rising demand for effective techniques are expected to drive the market growth in the region.

The United States PET scanners market led the North American market in 2023 and is expected to grow at the fastest rate during the forecast period. The COVID-19 epidemic in North America has significantly impacted healthcare systems. Additionally, PCR swabs have been found to have low sensitivity and a high rate of false negatives.

Mexico is predicted to have a significant proportion of the North American PET Scanners market after the United States. In addition, the increased prevalence of cancer cases, such as breast cancer and prostate cancer, is also expected to boost the market growth considerably. According to the GLOBOCAN 2023 study, total diagnosed cancer cases in Mexico in 2023 were 195,499, with breast and prostate cancers being the most common forms in the Mexican population.

KEY MARKET PLAYERS

Some of the major players in the market are Positron Corporation, Mediso Ltd., Siemens AG, Hitachi, Ltd., General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., and Yangzhou Kindsway Biotech Co. Ltd., among others